• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Information for the July 23, 2013 Meeting of the Arthritis Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance 
 
 
 
Morning Session
 
FDA
 
Disclaimer
 
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
 
FDA Briefing Information, Humira (Adalimumab) Injection, for the July 23, 2013 Meeting of the Arthritis Advisory Committee (PDF – 1.06MB)
 
 
 
 
AbbVie, Inc.
 
Disclaimer
 
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
 
AbbVie Briefing Information, Humira (Adalimumab) Injection, for the July 23, 2013 Meeting of the Arthritis Advisory Committee (PDF – 3.85MB)
 
 
Afternoon Session
 
FDA
 
Disclaimer
 
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
 
FDA Briefing Information, Cimzia (Certolizumab) Injection, for the July 23, 2013 Meeting of the Arthritis Advisory Committee (PDF – 1.40MB)
 
 
 
 
UCB, Inc.
 
Disclaimer
 
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
 
UCB Briefing Information, Cimzia (Certolizumab) Injection, for the July 23, 2013 Meeting of the Arthritis Advisory Committee (PDF – 3.42MB)
 
Errata to the UCB Briefing Information, Cimzia (Certolizumab) Injection, for the July 23, 2013 Meeting of the Arthritis Advisory Committee (PDF – 104KB)